Pro Test Diagnostics AB
Umeå-based diagnostics company developing a laboratory test kit to detect autologous blood transfusion (autologous blood doping). The company applies proteomics-based methods (liquid chromatography coupled to mass spectrometry), sample-preparation workflows, multivariate statistics and planned AI tools to identify biomarkers associated with long-term frozen storage of red blood cells. The organisation collaborates with accredited anti-doping laboratories and has progressed through pilot production, validation and funding rounds.
Industries
Nr. of Employees
small (1-50)
Products
Diagnostic kit for detection of autologous blood transfusion
A laboratory test kit designed to detect molecular fingerprint changes in blood caused by long-term frozen storage and re-infusion of an individual's own blood.
Diagnostic kit for detection of autologous blood transfusion
A laboratory test kit designed to detect molecular fingerprint changes in blood caused by long-term frozen storage and re-infusion of an individual's own blood.
Services
Validation testing and analytical transfer of the autologous blood transfusion detection assay to accredited anti-doping laboratories for use in routine testing.
Processing and statistical analysis of proteomics datasets to identify biomarkers indicative of stored/frozen red blood cells.
Validation testing and analytical transfer of the autologous blood transfusion detection assay to accredited anti-doping laboratories for use in routine testing.
Processing and statistical analysis of proteomics datasets to identify biomarkers indicative of stored/frozen red blood cells.
Expertise Areas
- Proteomics-based biomarker discovery
- LC-MS/MS analytical workflows for blood samples
- Diagnostic assay development for anti-doping
- Clinical study design and sample management
Key Technologies
- Liquid chromatography-mass spectrometry (LC-MS/MS)
- Nano-scale reversed-phase chromatography (nano-UHPLC)
- Electrospray ionization QTOF mass spectrometry
- Label-free proteomics
News & Updates
Awarded funding from the World Anti-Doping Agency to develop AI methods to pre-sort blood cells and detect changes from frozen storage.
Completed a pilot production run of diagnostic kits with an ISO-certified contract manufacturer and prepared kits for testing in accredited doping laboratories.
Submitted a research paper describing a method using nano-UPLC-MS/MS to detect cryopreserved autologous blood and separate doped from clean athletes.
Secured SEK 17 million in capital from investors to advance the diagnostic kit toward market introduction and validation.
News describing the plan to use AI to pre-sort blood cells and detect abnormalities from frozen blood storage; references WADA funding.
Ongoing grant support from the World Anti-Doping Agency for development of anti-doping methods focused on autologous blood detection.
Awarded funding from the World Anti-Doping Agency to develop AI methods to pre-sort blood cells and detect changes from frozen storage.
Completed a pilot production run of diagnostic kits with an ISO-certified contract manufacturer and prepared kits for testing in accredited doping laboratories.
Submitted a research paper describing a method using nano-UPLC-MS/MS to detect cryopreserved autologous blood and separate doped from clean athletes.
Secured SEK 17 million in capital from investors to advance the diagnostic kit toward market introduction and validation.
News describing the plan to use AI to pre-sort blood cells and detect abnormalities from frozen blood storage; references WADA funding.
Ongoing grant support from the World Anti-Doping Agency for development of anti-doping methods focused on autologous blood detection.